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Abstract
Background: Leukocyte-platelet rich fibrin (L-PRF) is a second generation platelet concentrate clinically used to 
accelerate tissue healing and bone regeneration. Achieving reduced implant osseointegration time could provide 
immediate or early loading of implants. The aim of this study was to evaluate the L-PRF-induced osseointegration 
and bone-implant contact (BIC) in an experimental animal model. 
Material and Methods: Twelve 4-month-old New Zealand white rabbits were used. Following general anesthesia, 
3-5 mL of blood was obtained from the central artery in rabbit ear and L-PRF was prepared. Two implant cavi-
ties (5 mm long and 3 mm in diameter) were created in each tibia with a total of four cavities in each animal. Two 
of these cavities were selected and covered with PRF (test group). The remaining L-PRF was used to soak the 
implants placed into the L-PRF covered sockets. Other cavities were left as controls. In total, 48 implants were 
placed. Animals were sacrificed after two, three, or four weeks. Histological samples were obtained and peri-
implant tissues were histomorphometrically evaluated for bone-to-implant contact and new bone formation. 
Results: Histomorphometric analyses of the defects revealed that the L-PRF was detectable up to the second 
week. Application of L-PRF increased the rate and amount of new bone formation in the experimental group 
compared to the control group. Bone-to-implant contact was enhanced when the surface was pre-wetted with L-
PRF (p<0.01).
Conclusions: The results of this study demonstrated that L-PRF application may increases amount and rate of new 
bone formation during the early healing period and provides a faster osseointegration around implants. 
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Introduction
Osseointegration of dental implants is critical for the 
long-term success and stability. Various strategies have 
been used to accelerate the time required for osseointe-
gration without compromising the mechanical out-
comes and tissue integration (1,2). The implant surface 
topography plays a key role in the early stages of bone-
to-implant contact (BIC); peri-implant bone forma-
tion depends on the healing capacity of the bone (2,3). 
Modification of the surface properties of the implants 
by chemical methods such as incorporation of inorganic 
phases on or into the titanium oxide layer and physical 
enhancement of the materials by increasing the level of 
roughness have successfully increased the BIC (3). An-
other strategy to reduce the osseointegration time has 
been the modulation of the healing response after the 
implant placement (2,3). This has been accomplished 
by biologically active molecules during implant place-
ment to induce osteoconductivity, increase osteoblas-
tic differentiation and enhance healing of peri-implant 
bone (3,4). Growth factors, bone-specific proteins, bone 
morphogenetic proteins induce better osseointegration 
through replication and differentiation of osteoprogeni-
tor cells and interfacial tissue maturation (3-8).
Platelet-based preparations from patient’s own blood 
provide an inexpensive alternative to commercially 
available bioactive materials. Activated platelets secrete 
a wide range of proteins and growth factors including, 
Bone Morphogenetic Protein (BMP), Platelet-Derived 
Growth factor (PDGF), Insulin - like Growth Factor 
(IGF), Vascular Endothelial Growth Factor (VEGF), 
Transforming Growth Factor-β1 (TGF-β1) and Trans-
forming Growth Factor-β2 (TGF-β2), which play key 
roles in bone healing (5-9). They attract undifferentiated 
mesenchymal cells to the injured site and facilitate an-
giogenesis, chemotaxis and cell proliferation. Growth 
factors also control the synthesis and degradation of 
extracellular matrix proteins, enhance osteogenesis and 
potentially accelerate peri-implant wound healing and 
osteointegration (8-11).
Leukocyte-Platelet rich fibrin (L-PRF) is a second gen-
eration of autologous platelet concentration and a fibrin 
mesh consisting of leukocytes, growth factors, proteins 
and cytokines (9). L-PRF, platelet rich plasma (PRP) 
and platelet rich growth factor (PRGF) are structurally 
different materials. L-PRF has advantages over PRP 
and PRGF by having a strong fibrin structure and not 
requiring any biochemical modification through bovine 
thrombin or anticoagulants (12,13). L-PRF has a very 
significant slow sustained release of key growth fac-
tors for at least 1 week and up to 28 days, which stimu-
lates its environment for a significant time during early 
phases of wound healing (10-14). Because of its natural 
fibrin framework properties, growth factors can keep 
their activity for a relatively longer period and promote 
tissue regeneration (15). When L-PRF was applied to 
the titanium implant surfaces, growth factors covered 
the implants forming a fibrin layer for platelets to ad-
here (5-8,15). Recently evaluated the effect of PRP and 
PRF on proliferation and differentiation of rat osteo-
blasts. This study showed that PRF released autologous 
growth factors gradually and expressed stronger and 
more durable effect on proliferation and differentiation 
of rat osteoblasts than PRP in vitro (14,15).
Yet, in vivo justification for L-PRF application during 
implant placement and its impact on osseointegration 
is limited. Therefore, we have hypothesized that imple-
mentation L-PRF around dental implants may lead to 
faster healing rates in peri-implant bone and decrease 
osseointegration time. In order to test this hypothesis, 
we have used a rabbit model and studied the effects of 
L-PRF on new bone formation and BIC around dental 
implants.
Material and Methods
- Animal Model, Preparation of the L-PRF and Surgical 
Procedure
The research protocol was submitted to and approved by 
the Institutional Animal Care and Use Committee and 
ethical board of animal investigations. Twelve 4-month 
old New Zealand white rabbits with an average weight 
of 3.0-3.5 kg were used. Each rabbit was individually 
caged and fed. General anesthesia was induced by intra-
muscular injection of a combination of 0.5 mL ketamine 
(20 mg/kg by body weight; Ketalar, Eczacıbası, Istanbul, 
Turkey) and 0.5 mL xylazine (10 mg/kg by body weight; 
Rompun, Bayer, Leverkusen, Germany). After general 
anesthesia, 3 to 5 mL of blood was obtained from the 
central artery of the ear. Samples were collected in 9 mL 
glass-coated plastic tubes without anti-clotting agent 
(Becton Dickinson Vacutainer, Franklin Lakes, NJ, USA) 
and immediately centrifuged at 2700 rpm for 12 min-
utes with a table centrifuge (PC-02, Process Ltd., Nice, 
France; Fig. 1A). The leukocyte-rich fibrin clot formed 
in the middle part of the tube was taken and remnants 
of red blood cells were scraped off with gauze. The clot 
was then transferred to the PRF box (Process Ltd., Nice, 
France), compressed and PRF membranes were obtained 
(Fig. 1B). Serum obtained during compression of the fi-
brin clot was transferred to a syringe.
Distal surfaces of right and left tibias were shaved 
and disinfected with a povidine-iodine solution. Local 
anesthesia was accomplished  (Ultracaine D-S®, Hoechst 
A.G, Turkey). Surgical procedures were performed 
by the same surgeon (E.Ö.). After a crestal incision, 
the muscles were dissected and a sharp subperiosteal 
dissection was used to reflect the periosteum to expose 
the tibia bone. Two implant site preparation, which 
were 5-mm apart from each other, were prepared. Mini 
implants specially produced for application in rabbit 
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tibia were used (SLA surface; Nucleoss, Izmir, Turkey). 
Two implants in left tibia were used as “test” and other 
two implants in the right tibia of the same animal were 
assigned as “control”. A total of 48 implants (3 mm 
width and 5 mm length) were used. L-PRF membranes 
were applied to test sockets (Fig. 1C). Test implants were 
thoroughly soaked with L-PRF before implant insertion 
(Fig. 1D) and placed (Fig. 1E). Control implants were 
placed without the PRF application (Fig. 1F). The 
periosteum and skin were closed in layers using 5-0 
resorbable sutures (Fig. 1G).
All animals were postoperatively medicated with in-
tramuscular amoxicillin (1.5 mg/kg body weight) for 
infection control and buprenorphine (10 mg) for pain 
relief. Animals were sacrificed on 2nd, 3rd and 4th weeks 
post-surgery and histological samples were obtained 
(Fig.  2).
- Histological Analyses 
Samples were fixed in neutral buffered formalin, dehy-
drated in 70%, 90%, 95% and 100% alcohol and embed-
ded in a blue light-curing resin (Technovit 7200 VLC; 
Kulzer, Wehrheim, Germany) for 48 hours. After the 
dehydration, each specimen was embedded in methyl-
methacrylate. Samples were then sectioned along the 
long axis of the implant using high-speed rotational 
microtome (Micromet, Remet, Italy). Finally, the sec-
tions were ground to a thickness of 40-µm and then 
were stained with 1% toluidine blue. Histological ex-
amination was made with Zeiss Axiovert 200 micro-
scope (Carl Zeiss inverted microscope for transmitted 
light and epifluorescence, Germany), which was con-
nected to a computer and photomicrographs were taken 
with a under UV light with a same microscope. Before 
performing image analysis, a specific region of inter-
est (ROI) had been determined. The proportion of new 
bone formation related areas of bone detected inside the 
ROI divided by the total surface area and analyzed the 
effect of L-PRF on bone formation, the newly formed 
bone on the surface of the implant and BIC were evalu-
ated. The total amount of new bone was calculated ac-
cording to percentage of the total region on the surface 
of the implant. The bone-to-implant contact was calcu-
lated by the percentage of the bony contact to the im-
plant surface.
- Statistical Analysis 
Statistical computations were carried out using IBM 
PASW/SPSS software (v.18.0.0 2009, IBM Corpora-
tion, Somers, NY, USA). Implants were included in the 
statistical analysis as independent values. Mean values 
and standard deviations were calculated for each vari-
able and group. The difference between groups was an-
alyzed with ANOVA and the difference within groups 
was analyzed with Student t-test.
Results
All implants successfully healed without any postop-
erative complications. No mortality, infection or wound 
exposure or change in body weight was noted. 
Histomorphometric analyses of the defects revealed that 
the L-PRF was detectable up to the second week (Fig. 
2D,3B). In the test group, L-PRF around implants was 
obvious on the third and fourth weeks with a substantial 
new bone formation. At the end of 4 weeks, new bone 
formation as stained with toluidine blue around implant 
was limited with almost no bone contact on the implant 
surface in the control group (Fig. 3C). Widely stained 
bone formation and almost complete healing around 
implants were observed in the L-PRF group (Fig. 3D). 
Application of L-PRF increased the rate and amount of 
new bone formation in the experimental group com-
pared to the control group (31.7% ± 6.8% vs 12.1% ± 
7.7% at third week and 39.9% ± 3.9%  vs  26.4% ± 9.0% 
at fourth week,  p<0.01). 
There was a rapid increase in the percentage of new 
bone formation and BIC in the test group (Fig. 4). Bone-
to-implant contact was enhanced when the surface was 
pre-wetted with L-PRF (52.6% ± 21.7%  vs 36.0% ± 
23.2%  at third week and 54.6% ± 5.2% vs  39.0% ± 
8.9% at fourth week  p<0.01).
There was no evidence for fibrotic tissue layer formation 
Fig. 1. Study design and sequence of events. Panel A. L-PRF clot 
in the middle of the tube, Panel B. Fibrin clots transferred to L-
PRF Box, Panel C. The implants were washed completely, Panel 
D. L-PRF membrane placed in implant socket, Panel E. Implants 
placed in sockets which coated with L-PRF, Panel F. Implants 
placed in sockets in control group, Panel G. The periosteum and 
skin were closed in a layer using 5-0 vicryl resorbable sutures.
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in any groups. The percentage of new bone formation 
around the implants in the test group was significantly 
higher than the control group (P < 0.01). Likewise, the 
BIC was significantly higher in the test group than the 
control group on the third and fourth weeks (P < 0.01).
Discussion
We have investigated the potential effects of L-PRF on 
stimulating bone regeneration and accelerating the os-
seointegration of dental implants. The histomorphomet-
ric results showed the rate of bone formation and BIC 
were enhanced in the L-PRF treated sockets compared 
to the empty sockets after the implant placement. 
In this study mean bone-to-implant contact in the 4th 
week was 54.61% in the experimental group and 26.44% 
in the control group. The findings of this study were in 
agreement with the results reported by Anitua et al. Us-
ing a similar approach, these authors reported a 51% BIC 
when implants were coated with PRGF compared to the 
22% BIC of the control group after 8 weeks of healing 
time (5-8). Our results also confirm the data presented 
by Lee et al. who have reported that the mean new bone 
formation was 29% in the experimental group and 11% 
in the control group with a BIC of 39% vs 17% (16). Fur-
thermore, our results support the findings by Fontana et 
al. and those of another study where PRP improved BIC 
for roughened implants inserted in rat tibias (11,15). Us-
ing a similar approach, Fuerst et al. reported a 55% BIC 
when implants were coated with PRGF versus 39% of 
the control group after 4 weeks of healing time (17). 
In another rabbit study, histomorphometric results 
showed that during the first 2-3 weeks, integration of tita-
nium mini-screws and bones was weak but after 4 weeks 
of healing integration of titanium mini-screws and bones 
was significantly stronger. They stated that four weeks is 
a critical time point during the progress of integration of 
titanium mini-screws and bones (18). In this study there 
is virtually no difference in BIC in the control group be-
tween 2, 3 and 4 weeks, these results may have been due 
to the lack of sufficient time for osseointegration in the 
Fig. 2. Second, third and fourth weeks macroscopic view of the test and 
control groupsafter sacrifice. Panel A. The image of the control group at 2nd 
week, Panel B. The image of the control group at 3rdweek, Panel C.The im-
age of the control group at 4th week, Panel D.The image of the test group at 
2nd week, L-PRF was not resolved in the second week of the test groups was 
shown by the red arrow, Panel E. The image of the test group at 3rd week, 
implants uppermost coated with bone tissue, Panel F. The image of the test 
group at 4th week, implants cannot be observed due to new bone formation 
at the peak of the implants.
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Fig. 3.  Photographs of the histological sections seen by light microscopy at sec-
ond and fourth week view of the image in test and control groups. Sections were 
stained with toluidine blue. Original magnification, 20×. Panel A.Photographs of 
the histological sections seen by light microscopy at 2nd weeks in control group, 
percentage of new bone formation and bone to implant contact was shown. Panel 
B Photographs of the histological sections seen by light microscopy at 2nd weeks 
in test group, L-PRF was not resolved in the second week of the test groups was 
shown. Panel C. Photographs of the histological sections seen by light micros-
copy at 4th weeks in control group, percentage of new bone formation and bone 
to implant contact was seen, there was almost no bone contact in the uppermost 
on the implant surface . Panel D. Photographs of the histological sections seen by 
light microscopy at 4th weeks in test group, the regenerated bone covered nearly 
all the surface in this group. 
!
!
Fig. 4. Percentage of new bone formation in the test and control groups.
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control groups. Histomorphometric results showed BIC 
in theexperimental group than in the control in the 3rd 
and 4th weeks. Differences between groups may be from 
the fact that either follow-up period is short for osseointe-
gration, or PRF speeds up the healing.
Some researchers argue that the growth factors re-
leased by platelets play an important role in enhancing 
the bone response and in the transformation of mar-
row bone cells into osteoblasts (7,10-15). Other studies 
have also demonstrated the potential effects of different 
platelet rich products in accelerating the regeneration 
of bone tissues. It is thought that the implant surfaces 
activate the platelets leading to a rapid osteointegration 
(5,8,19). Platelet Rich Fibrin is a recognized support ma-
trix for BMP transplants. Therefore, the fibrin matrix 
associated with BMPs has angiotrophic, hemostatic, 
and osseous conductive properties (10,20). L-PRF may 
improve and accelerate osteogenesis (10). Previously, 
PDGF and PRP were applied around implants in order 
to provide the regeneration of bone and increase BIC 
in many studies (7-10). We preferred L-PRF, because 
L-PRF, PRP and PRGF are structurally different mate-
rials. The advantages of PRF technique over PRP and 
PRGF  include shorter time of preparation, lack of re-
quiring anticoagulant and bovine thrombin. In course 
of the platelet and fibrinogen activation of PRGF and 
PRP growth factors and some other proteins are not en-
meshed in the fibrin network, because the fibrin polym-
erization is incomplete. These molecules are therefore 
released quickly during the first hours after preparation. 
Furthermore these products do not contain leukocytes 
and cannot sustain the production of new growth factors 
after the initial release. On the other hand, the strong fi-
brin architecture of the L-PRF allows an intense slow 
release throughout the entire span of the experiment, 
and the release is further supported by the production 
of new growth factors by the leukocytes living in the 
L-PRF membrane (4,11,17,18,21). When L-PRF applied 
to the implant surface, a protein layer involving mas-
sive growth factors are constituted. This regeneration 
potential may stimulate the healing of implant on the 
surrounding bone with the platelet rich layer (4).
To our knowledge, the present study is the first experi-
mental study, which evaluated the effect of L-PRF on 
osseointegration. Within the limits of our study, we 
concluded that L-PRF application during implant place-
ment may increases the rate and enhances the osseointe-
gration providing a convenient and affordable choice 
for implant placement especially in sites where earlier 
loading may be required. Clinical studies are needed to 
demonstrate efficacy in humans.
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